Mangoceuticals (MGRX) Assets Average (2023 - 2026)

Mangoceuticals has disclosed Assets Average across 4 years of filings, most recently posting $15.3 million for Q1 2026.

• Assets Average for Q1 2026 came in at $15.3 million, down 17.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.3 million (down 17.74% YoY), and the FY2025 annual result was $15.7 million, up 91.58% from the prior year.
• Assets Average came in at $15.3 million for Q1 2026 at Mangoceuticals, down from $16.3 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $21.3 million in Q2 2025 to a low of $676120.0 in Q1 2024.
• The 4-year median for Assets Average is $15.0 million (2024), against an average of $10.7 million.
• Across the five-year window, Assets Average slumped 73.58% in 2024 and soared 2645.4% in 2025, its largest moves.
• Mangoceuticals' Assets Average stood at $1.3 million in 2023, then soared by 1039.8% to $15.1 million in 2024, then advanced by 8.15% to $16.3 million in 2025, then slipped by 6.38% to $15.3 million in 2026.
• The last three Assets Average figures came in at $15.3 million (Q1 2026), $16.3 million (Q4 2025), and $18.7 million (Q3 2025), per Business Quant data.